Peptide Academy · Approved peptides · Education only

Bremelanotide: What FDA Approved, Explained Simply

By BioLabs Research · Peptide Academy › Approved Peptides

Bremelanotide comes from a family of peptides called melanocortins. The family name hints at its first-known job: melanin, the pigment in skin. Researchers later found that melanocortin receptors also exist in the brain, and that discovery eventually led to an FDA approval.

On this page we'll keep it simple: what bremelanotide is, what it does according to the official FDA label, and exactly what FDA approved. Nothing here is advice on using a medicine. Approved medicines are prescribed by licensed clinicians, and the official label is always the controlling text.

What it is

Bremelanotide is a synthetic peptide that activates melanocortin receptors. It is a cyclic peptide, meaning its chain is joined into a ring, which helps make it stable.

What it does

Section 12.1 of the FDA label describes bremelanotide as a melanocortin receptor agonist. It activates several receptor subtypes without being selective, in this order of potency: MC1R, MC4R, MC3R, MC5R, MC2R. The label says binding to MC1R and MC4R is most relevant, and that MC4R-expressing neurons are found in many areas of the central nervous system. Importantly, the label states that the mechanism by which it works for its approved indication is unknown.

For a deeper dive, see the peer-reviewed review: Drugs 2019 — 'Bremelanotide: First Approval' (PubMed 31429064).

What FDA approved

Labelled indication: Treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized on the label: low sexual desire causing marked distress or interpersonal difficulty that is not due to a co-existing medical or psychiatric condition, problems with the relationship, or the effects of a medication or drug substance.

The approval is limited to the population and definition written on the label.

Regulatory status at a glance

A common misunderstanding

Because MC1R sits on pigment cells, the label also discusses effects related to skin pigmentation. That's a good example of how one peptide can touch several receptor 'locks' in different tissues.

What FDA approval actually means

Here's the part most people get wrong. FDA approval is narrow. It covers a specific product, from a specific manufacturer, for a specific use, in a specific group of patients, with a specific label. The approval does not belong to the molecule floating around in the world. A chemical with the same name, sold by someone else for any other purpose, is not an approved drug. That's why we quote the label's own indication and nothing more.

How we checked these facts

Every regulatory fact on this page comes from an official U.S. government source: the Drugs@FDA database (and its openFDA API) for the application number and approval date, and the current FDA label on DailyMed for the indication, boxed warning and mechanism. Mechanism background also comes from a peer-reviewed review indexed in PubMed. We don't reproduce usage instructions from labels. This is an education page, not a guide to using any medicine.

Why approved peptides matter for peptide science

Approved peptides prove that peptide research can turn into real medicines. They also show how high the bar is: controlled human trials, manufacturing inspections, a written label, and safety monitoring that continues after approval. Most peptides you read about online never got anywhere near that bar. Chapter 7 of the Academy explains where the line sits.

FAQ

Does the FDA label explain how bremelanotide works for HSDD?
The label states the mechanism for this indication is unknown.

Which receptors does it act on?
Per the label: melanocortin receptors, most relevantly MC1R and MC4R.

Is this page medical advice?
No. It is education only. Talk to a licensed healthcare professional about any medicine.

References: Drugs@FDA; openFDA; DailyMed label; PubMed review.

← All approved peptides · Peptide Academy home